1: Oshio S, Ozaki S, Ohkawa I, Tajima T, Tomomasa H, Amemiya H, Yazaki T, Mohri H, Umeda T. Spermicidal activity of menfegol-coated condom. Andrologia. 1990 May-Jun;22(3):291-6. PubMed PMID: 2240626.
2: Chompootaweep S, Dusitsin N. A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol-9 versus menfegol) in Thai women. Contraception. 1990 May;41(5):507-17. PubMed PMID: 2161308.
3: Oshio S, Tomomasa H, Amemiya H, Yazaki T, Umeda T, Mohri H, Ozaki S, Ohkawa I, Tajima T. [Effects of a condom coated with menfegol, a spermicide, on sperm motility and viability]. Nihon Funin Gakkai Zasshi. 1989 Oct;34(4):914-8. Japanese. PubMed PMID: 12158569.
4: Yamai S, Kuroki T, Watanabe Y, Takizawa K. In vitro effect of menfegol on Neisseria gonorrhoeae. Kansenshogaku Zasshi. 1989 Oct;63(10):1178-81. PubMed PMID: 2515225.
5: Goeman J, Ndoye I, Sakho LM, Mboup S, Piot P, Karam M, Belsey E, Lange JM, Laga M, Perriëns JH. Frequent use of menfegol spermicidal vaginal foaming tablets associated with a high incidence of genital lesions. J Infect Dis. 1995 Jun;171(6):1611-4. PubMed PMID: 7769301.
6: Chantler E, Fisher H, Solanki S, Elstein M. Quantification of the in vitro activity of some compounds with spermicidal activity. Contraception. 1992 Dec;46(6):527-36. PubMed PMID: 1283567.
7: Connell EB. Barrier contraceptives. Clin Obstet Gynecol. 1989 Jun;32(2):377-86. Review. PubMed PMID: 2663278.
8: Jones BM, Willcox LM. The susceptibility of organisms associated with bacterial vaginosis to spermicidal compounds, in vitro. Genitourin Med. 1991 Dec;67(6):475-7. PubMed PMID: 1774052; PubMed Central PMCID: PMC1194771.
9: Zaneveld LJ, Waller DP, Ahmad N, Quigg J, Kaminski J, Nikurs A, De Jonge C. Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents. J Androl. 2001 May-Jun;22(3):481-90. PubMed PMID: 11330649.
10: Jennings R, Clegg A. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro. J Antimicrob Chemother. 1993 Jul;32(1):71-82. PubMed PMID: 7693643.
11: Youssef H, Crofton VA, Smith SC, Siemens AJ. A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt. Contraception. 1987 Feb;35(2):101-10. PubMed PMID: 3297482.
12: Lamptey P, Klufio C, Smith SC, Feldblum PJ. A comparative study of Neo Sampoon, Ortho Vaginal Tablets and Emko Vaginal Tablets in Accra, Ghana. Contraception. 1985 Nov;32(5):445-54. PubMed PMID: 3002720.
13: Chi IC, Smith SC, Borko E, Sun TH, Begum SF, Hunt WL, Wilkens LR. Clinical acceptability, use-patterns and use-effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets--an international multi-center randomized clinical trial. Contraception. 1987 Nov;36(5):499-514. PubMed PMID: 3329078.
14: Furuse K, Ishizeki C, Iwahara S. Studies on spermicidal activity of surfactants. I. Correlation between spermicidal effect and physicochemical properties of p-menthanylphenyl polyoxyethylene (8.8) ether and related surfactants. J Pharmacobiodyn. 1983 Jun;6(6):359-72. PubMed PMID: 6631657.
15: Borko E, McIntyre SL, Feldblum PJ. A comparative clinical trial of the contraceptive sponge and Neo Sampoon tablets. Obstet Gynecol. 1985 Apr;65(4):511-5. PubMed PMID: 2984617.
16: Begum SF, Liao WC, McCann MF, Ahmad N. A clinical trial of Neo Sampoon vaginal contraceptive tablets. Contraception. 1980 Dec;22(6):573-82. PubMed PMID: 7214907.
17: Rosenberg M. Contraception and STDs. IPPF Med Bull. 1991 Oct;25(5):3-4. PubMed PMID: 12284650.
18: Berman SM. Fertility control and HIV infection. Arch AIDS Res. 1991;5(1-2):25-7. PubMed PMID: 12284239.
19: Edelman DA. The vaginal contraceptive sponge. IPPF Med Bull. 1984 Jun;18(3):1-2. PubMed PMID: 12266284.
20: Hong CY, Chiang BN, Ku J, Wei YH. Glutathione and caffeine antagonize the sperm-immobilizing effect of a vaginal contraceptive. Hum Toxicol. 1984 Aug;3(4):271-7. PubMed PMID: 6480005.